close
MENU
Hot Topic Aus election
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Morning Brew The Grind Entrepreneurs Your Business Beehive Banter Toil & Trouble Market Outlook Dollars & Sense Private Bin Audio Articles NZ Aviation News Back Issues Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Aus election
General Business
4 mins to read
2

Clinical trial companies merge under Pencarrow majority ownership

Combined company keen to target larger slice of global clinical trial market.

Will Mace Fri, 22 Oct 2021

An investment by Pencarrow Private Equity has brought together two regional clinical trial research companies to bolster their capabilities and target untapped growth in the Asia-Pacific market.

Lakeland Clinical Trials (LCT) of Rotorua and Southern Clinical Trials (SCT) of Christchurch have

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Already have an account? Login
Will Mace Fri, 22 Oct 2021
Contact the Writer: william@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
pencarrow private equity Pacific Clinical Research Network PCRN clinical trials

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Related News
General Business
1

NZ clinical trial boom post-Covid slowly but surely emerging
General Business
2

Covid brings boom in clinical trials

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Related News
General Business
1

NZ clinical trial boom post-Covid slowly but surely emerging
General Business
2

Covid brings boom in clinical trials

Clinical trial companies merge under Pencarrow majority ownership
General Business,
89359
true
Subscribe Login